YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
LOS ANGELES, September 02, 2026--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management…
LOS ANGELES, August 26, 2026--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management wi…
In early August 2026, Niagen Bioscience Inc. reported slightly lower quarterly sales and net income year on year, while also expanding access to its Tru Niagen® healthy‑aging NAD+ supplement via Walmart.com, initially offering 300 mg bottl…
[Wall Street sign, New York City, USA] mbbirdy/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-down moves before the bell on Wednesday. U.S. stock index futures rose on Wednesday as Wall Street looked to continue…
This article first appeared on GuruFocus. Release Date: August 04, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Niagen Bioscience Inc (NASDAQ:NAGE) reported stron…
Earnings Call Insights: Niagen Bioscience (NAGE) Q2 2026 MANAGEMENT VIEW * "This quarter marks another important milestone in the evolution of Niagen Bioscience" (CEO & Director Robert Fried) and "today, we are becoming something much broa…
Collaboration will support pharmacokinetic, pharmacodynamic, and bioanalytical studies for Niagen Bioscience's lead investigational candidate for rare pediatric diseases Evotec brings deep drug development expertise, serving leading pharma…
Bristol Myers Squibb (BMY) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $1.59 per share. This compares to earnings of $1.46 per share a year ago. These figures are adjusted for non-recurring…
Niagen Bioscience Inc. (NASDAQ:NAGE) is one of the high-growth micro-cap stocks to buy now. On June 2, Niagen Bioscience Inc. (NASDAQ:NAGE) renamed the ChromaDex External Research Program (CERP) to the Niagen Research Program to underscore…
Over the last 7 days, the United States market has risen 1.1%, contributing to a substantial 27% increase over the past year, with earnings projected to grow by 17% annually. The term 'penny stocks' might feel like a relic of past market e…
The United States market has shown impressive growth, with a 1.1% increase over the last week and a substantial 27% rise over the past year, alongside expectations for earnings to grow by 17% annually in the coming years. Penny stocks, whi…
Over the last 7 days, the United States market has risen by 2.2%, and over the past year, it has increased by 31%, with earnings forecasted to grow annually by 17%. In light of these conditions, investors may find value in smaller or newer…
StoneX Group Inc. NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- The Benchmark Company, a subsidiary of StoneX Group Inc. (“StoneX”; NASDAQ: SNEX), is pleased to announce its 4TH Annual Consumer One-on-One Conference at the New York Athletic C…
The market has climbed 1.8% in the last 7 days and is up 30% over the past year, with earnings projected to grow by 16% annually. Penny stocks, while a somewhat outdated term, continue to represent intriguing investment opportunities for t…
The market remained flat over the last week, yet it is up 28% over the past year with earnings expected to grow by 16% per annum in the coming years. In this context, identifying stocks that combine solid financials with growth potential i…
In the last week, the market has stayed flat, but over the past 12 months, it has risen by 29%, with earnings forecast to grow by 16% annually. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or n…
Over the last 7 days, the market has remained flat, yet it is up 28% over the past year with earnings forecasted to grow by 16% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities for growth at low…
The United States market remained flat over the last week, but it has seen a significant 28% increase over the past year with earnings expected to grow by 16% annually. In light of these conditions, identifying stocks with strong fundament…
The market remained flat over the last week, but it has seen a remarkable 30% increase over the past year, with earnings expected to grow by 16% annually. For those looking to invest in smaller or newer companies, penny stocks—despite thei…
In the last week, the market has been flat, but over the past 12 months, it has risen by 30%, with earnings expected to grow by 16% annually in the coming years. In this context, identifying stocks with strong financial health is crucial f…
Niagen Bioscience Inc. (NASDAQ:NAGE) is one of the 10 best consumer staples penny stocks to buy now. On April 9, Niagen Bioscience Inc. (NASDAQ:NAGE) announced that Nicotinamide Riboside Chloride, the patented form of nicotinamide riboside…
Over the last 7 days, the U.S. market has risen 1.3%, and over the past year, it is up by an impressive 35%, with earnings forecasted to grow annually by 16%. In light of these robust market conditions, identifying stocks with strong funda…
Over the last 7 days, the United States market has risen by 1.3%, and in the past year, it has climbed an impressive 35%, with earnings forecasted to grow annually by 16%. In light of these market conditions, investors may find value in ex…
Over the last 7 days, the United States market has risen 3.6%, and over the past year, it has climbed 39%, with earnings expected to grow by 16% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities…
The market has shown impressive growth, climbing 3.6% over the last week and 39% in the past year, with earnings forecasted to grow by 16% annually. While the term 'penny stocks' might seem outdated, these stocks continue to offer a unique…
The market has climbed 4.0% in the last 7 days and 39% over the past year, with earnings forecast to grow by 16% annually. Though often considered outdated, penny stocks still hold potential when supported by robust financials, offering op…
Over the last 7 days, the United States market has risen by 4.0%, and over the past year, it has climbed 39%, with future earnings expected to grow annually by 16%. For those interested in smaller or newer companies, penny stocks — despite…
Over the last 7 days, the United States market has experienced a significant downturn, dropping 29%, and is down 82% over the past year, though earnings are forecast to grow by 16% annually. In challenging market conditions like these, ide…
Over the last 7 days, the United States market has dropped 29%, and in the past year, it is down 82%, though earnings are forecast to grow by 16% annually. Despite these challenging conditions, identifying stocks with solid financials can…
The market has shown impressive growth, with a 4.2% increase over the last week and a 29% rise over the past year, while earnings are projected to grow by 16% annually. Although the term 'penny stock' may seem outdated, it still represents…
The market has climbed 4.2% in the last 7 days and is up 29% over the past year, with earnings forecast to grow by 16% annually. For investors interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—can…
The market has shown robust performance, rising 3.1% over the last week and 27% over the past year, with earnings expected to grow by 16% annually in the coming years. In light of these conditions, identifying stocks with solid financials…
The United States market has shown robust performance, climbing 3.1% over the last week and 27% over the past year, with earnings projected to grow by 16% annually. In this context of market growth, identifying stocks with strong financial…
The market has climbed 3.4% in the last 7 days and an impressive 30% over the past year, with earnings projected to grow annually by 16%. In light of these robust market conditions, identifying stocks with strong financials becomes crucial…
Over the last 7 days, the United States market has risen by 3.4%, and over the past year, it has climbed 30%, with earnings expected to grow by 16% annually. In such a thriving market, identifying stocks with strong financials becomes cruc…
Niagen Bioscience, Inc. (NASDAQ:NAGE) is among the 12 Cheap Penny Stocks to Invest In Now. On March 31, Niagen Bioscience, Inc. (NASDAQ:NAGE) announced a strategic partnership with OneSpaWorld to offer pharmaceutical-grade Niagen IV treatm…